SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,733,000 | -16.4% | 48 | +9.1% | 0.00% | 0.0% |
| Q2 2019 | $8,055,000 | +87.6% | 44 | +63.0% | 0.00% | 0.0% |
| Q1 2019 | $4,294,000 | +66.0% | 27 | 0.0% | 0.00% | – |
| Q4 2018 | $2,586,000 | -81.5% | 27 | -72.7% | 0.00% | -100.0% |
| Q3 2018 | $13,983,000 | -2.9% | 99 | +7.6% | 0.00% | 0.0% |
| Q2 2018 | $14,401,000 | +119908.3% | 92 | +27.8% | 0.00% | 0.0% |
| Q1 2018 | $12,000 | – | 72 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |